Literature DB >> 90138

Urinary glycosaminoglycans in patients with progressive myoclonus epilepsy.

A Federico, N D'Auria.   

Abstract

Urinary GAGs analysis in Progressive Myoclonus Epilepsy (PME) showed an accumulation of uronic acid in the fraction eluted by 1 M NaCl and 3 M NaCl. As analogous changes were found in other myoclonic and epileptic patients receiving large doses of anticonvulsant drugs, these alterations in the GAG urinary pattern were not considered a primary disturbance of PME.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 90138     DOI： 10.1007/BF00314153

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  10 in total

1.  The excretion patterns of urinary glucosaminoglycans in a family with progressive familial myoclonus epilepsy.

Authors:  J H Poulsen
Journal:  Acta Neurol Scand       Date:  1975-09       Impact factor: 3.209

2.  Changes of brain glyco-conjugates in Unverricht-Lundborg's disease.

Authors:  A Federico; R Corona; G C Guazzi
Journal:  Acta Neurol (Napoli)       Date:  1978 Jan-Feb

3.  Content and composition of urinary glycosaminoglycans in the patients with myoclonus epilepsy with and without Lafora bodies.

Authors:  G Constantopoulos; A S Dekaban; J K Steusing; R Eldridge
Journal:  Acta Neurol Scand       Date:  1977-10       Impact factor: 3.209

4.  Myoclonus epilepsy with cerebellar Lafora bodies. Report of a case.

Authors:  R Scelsi; G L Mazzella; M Lombardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

5.  Lafora's disease. An ultrastructural and histochemical study.

Authors:  S Ramón y Cajal; A Blanes; A Martinez; E Sáenz; M Gutierrez
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

6.  Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.

Authors:  S Yokoi; J Austin; F Witmer; M Sakai
Journal:  Arch Neurol       Date:  1968-07

7.  Progressive myoclonus epilepsy without Lafora bodies.

Authors:  W B Matthews; D A Howell; D L Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-04       Impact factor: 10.154

8.  Mycolonus epilepsy with cherry-red spot in adult: a peculiar form of mucopolysaccharidosis. (A clinical genetic, chemical and ultrastructural study).

Authors:  G C Guazzi; B Ghetti; F Barbieri; A Cecio
Journal:  Acta Neurol (Napoli)       Date:  1973 Sep-Oct

9.  Muscle in Lafora disease.

Authors:  D L Coleman; P Gambetti; S D Mauro; R E Blume
Journal:  Arch Neurol       Date:  1974-12

10.  Findings in routine laboratory examination in progressive myoclonus epilepsy.

Authors:  M Koskiniemi
Journal:  Acta Neurol Scand       Date:  1975-01       Impact factor: 3.209
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.